Wagstaff, K.M.; Stein, M.S.; Herschtal, A.; Rajter, J.-J.; Rajter, J.C.; Sallaberger, M.; Smileski, A.; Kanagalingam, A.; Jans, D.A.
A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2. Pharmaceutics 2025, 17, 1205.
https://doi.org/10.3390/pharmaceutics17091205
AMA Style
Wagstaff KM, Stein MS, Herschtal A, Rajter J-J, Rajter JC, Sallaberger M, Smileski A, Kanagalingam A, Jans DA.
A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2. Pharmaceutics. 2025; 17(9):1205.
https://doi.org/10.3390/pharmaceutics17091205
Chicago/Turabian Style
Wagstaff, Kylie M., Mark S. Stein, Alan Herschtal, Jean-Jacques Rajter, Juliana Cepelowicz Rajter, Michele Sallaberger, Alexia Smileski, Amala Kanagalingam, and David A. Jans.
2025. "A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2" Pharmaceutics 17, no. 9: 1205.
https://doi.org/10.3390/pharmaceutics17091205
APA Style
Wagstaff, K. M., Stein, M. S., Herschtal, A., Rajter, J.-J., Rajter, J. C., Sallaberger, M., Smileski, A., Kanagalingam, A., & Jans, D. A.
(2025). A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2. Pharmaceutics, 17(9), 1205.
https://doi.org/10.3390/pharmaceutics17091205